NR2B subtype-selective NMDA receptor antagonists: 2001 – 2004

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.15, Iss.4, 2005-04, pp. : 389-407

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Advances in the Development of NR2B Subtype-Selective NMDA Receptor Antagonists

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 7, 2006-04 ,pp. : 697-709

Bentham Science Publishers

Access to resources Recommend Favorite

NR2B Selective NMDA Receptor Antagonists

Current Pharmaceutical Design, Vol. 8, Iss. 10, 2002-05 ,pp. : 845-855

Bentham Science Publishers

Access to resources Recommend Favorite

NMDA receptor antagonists as analgesics: focus on the NR2B subtype

By Chizh B.A. Headley P.M. Tzschentke T.M.

Trends in Pharmacological Sciences, Vol. 22, Iss. 12, 2001-12 ,pp. : 636-642

Elsevier

Access to resources Recommend Favorite

The NMDA receptor NR2B subtype selective antagonist Ro 25-6981 aggravates paroxysmal dyskinesia in the dt sz mutant

By Richter A.

European Journal of Pharmacology, Vol. 458, Iss. 1, 2003-01 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

Selective NR2B NMDA receptor antagonists are protective against staurosporine-induced apoptosis

By Williams A.J. Dave J.R. Lu X.M. Ling G. Tortella F.C.

European Journal of Pharmacology, Vol. 452, Iss. 1, 2002-09 ,pp. : 135-136

Elsevier

Access to resources Recommend Favorite